Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!
The goal of the project is to develop five to ten promising and tested new compounds for fighting multidrug-resistant infection caused by staph and related microbes, including vancomycin-resistant Enterococcus. The five-year project will be led by Michael Gilmore, PhD.
Related Articles on Antibiotic-Resistant Bacteria:
Most Hospital Uniforms Carry Bacteria, Study Shows
Tennessee Hospitals Improve Quality, Infection Control
New Bill Would Require Facility-Wide Plan From New Jersey Hospitals to Prevent Spread of MRSA
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.